By Editor , 19 October 2026
Capricor to Present 24-Month Deramiocel Data Ahead of Nov. 22 PDUFA

San Diego – October 19, 2026 -- Capricor Therapeutics (NASDAQ: CAPR) will present 24-month skeletal muscle and cardiac data from its Phase 3 HOPE-3 trial of Deramiocel in Duchenne muscular dystrophy (DMD) at the World Muscle Society Congress, weeks ahead of an FDA PDUFA target action date of November 22, 2026.

The 31st Annual Congress (WMS 2026) runs September 29 to October 3, 2026, in Hiroshima, Japan. Capricor will deliver one late-breaking poster and one oral presentation on Deramiocel, plus two preclinical posters from its StealthX exosome platform.

By Editor , 19 October 2026
Capricor: Deramiocel Cuts Upper Limb Decline 76% in HOPE-3 Extension

San Diego – October 19, 2026 -- Capricor Therapeutics (NASDAQ: CAPR) reported that Duchenne muscular dystrophy patients who switched from placebo to Deramiocel after one year slowed their upper limb decline by 76% compared with their own prior year, according to open-label extension data from the Phase 3 HOPE-3 trial. The U.S. FDA has set a PDUFA target action date of November 22, 2026, for the therapy.

By Editor , 19 October 2026

Tokyo – October 19, 2026 -- Japan's Ministry of Economy, Trade and Industry (METI) drew more than 10,000 visitors to Global Startup EXPO 2026 (GSE2026) in Osaka and named 10 winners at the Nippon Startup Awards 2026, putting robotics and genome-editing startups at the center of its deep-tech push.

By Editor , 19 October 2026
Trend Micro Offers Up to ¥10B in Credits for Japan Cyber Push

Tokyo – October 19, 2026 -- Trend Micro (TSE: 4704) plans to make available up to ¥10 billion in TrendAI Flex licensing credits under a new Japan Cyber Resilience Initiative, as publicly disclosed cyber incidents in Japan hit 607 in the first nine months of 2026, already above the 594 recorded for all of 2025.

The incident tally comes from TrendAI threat research and is current as of October 9, 2026. Trend Micro notes the figure may change as incidents are disclosed retroactively and further cases are added.

By Editor , 19 October 2026
NTT DATA Named Leader in IDC MarketScape Sustainability Assessment

Tokyo – October 18, 2026 -- NTT DATA has been named a Leader in the IDC MarketScape: Worldwide Sustainability Strategy Services 2026 Vendor Assessment, which evaluated 16 vendors on how they help enterprises embed sustainability into corporate strategy, operations and value creation.

By Editor , 15 October 2026
MetaTech AP Revenue Up 21% to NT$1.391B, Eyes Regenerative Medicine

Taipei – October 15, 2026 -- MetaTech AP Inc. (TPEx: 3224) reported revenue of NT$1.391 billion for the first nine months of 2026, up 21% year over year. The company outlined its 2027 strategy at an investor conference, with electronics and biomedicine as its two growth engines.

By Editor , 14 October 2026
Nanoscope Hires Ex-AveXis Supply Chain Chief Ahead of MOGENRY Review

Dallas – October 14, 2026 -- Nanoscope Therapeutics has appointed Troy Short, who built the global supply chain for Zolgensma across more than 30 countries at AveXis, as Senior Vice President of Manufacturing and Supply Chain while its lead gene therapy MOGENRY is under regulatory review in the United States and Japan.

By Editor , 14 October 2026
Taisei, TIER IV Win MLIT Autoflow Road Autonomous Logistics Trial

Tokyo – October 14, 2026 -- Taisei Corporation, TIER IV, Inc. and Taisei Rotec Corporation have been selected by Japan's Ministry of Land, Infrastructure, Transport and Tourism (MLIT) for a FY2026 demonstration project to accelerate deployment of the Autoflow Road, a logistics system that moves cargo with unmanned, automated vehicles in purpose-built lanes.

By Editor , 14 October 2026
DOCOMO, Abside Networks Sign MOU on AI-Driven HAPS Networks

Tokyo – October 13, 2026 -- NTT DOCOMO, INC. and Boston-based Abside Networks, Inc. signed a memorandum of understanding on October 13, 2026, to jointly study high-altitude platform station (HAPS) communications and AI-driven network control for next-generation infrastructure.